List of works - Florian Handle

AR variants: lost in translation to clinical practice?

scientific article published on 01 August 2019

Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide.

scientific article published on 29 July 2016

Drivers of AR indifferent anti-androgen resistance in prostate cancer cells

scientific article published on 24 September 2019

Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy

scientific article published on 27 November 2017

Fractionated Radiation of Primary Prostate Basal Cells Results in Downplay of Interferon Stem Cell and Cell Cycle Checkpoint Signatures

scientific article published on 18 June 2018

IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9 ⬇️

scientific article published on August 23, 2013

Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbits

scientific article

Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy

scientific article published on March 2015

On the use of frequency-domain reconstruction algorithms for photoacoustic imaging ⬇️

scientific article published on August 1, 2011

PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer.

scientific article published on 10 August 2015

SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells.

scientific article published on 6 April 2016

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse

scientific article published on 06 September 2021

The AR/NCOA1 axis regulates prostate cancer migration by involvement of PRKD1.

scientific article published on 2 June 2016

The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy.

scientific article published on 20 November 2017

The STAT3 inhibitor galiellalactone reduces IL6-mediated AR activity in benign and malignant prostate models

scientific article published on 25 September 2018

The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling.

scientific article published on 29 May 2017

The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells

scientific article published on 13 December 2019

p300 is up-regulated by docetaxel and is a target in chemoresistant prostate cancer

scientific article published on 01 January 2020

List of works by Florian Handle